@article{0c2c8e0fdf2e45fcba389ff01acc5135,
title = "Probing for Vulnerable Plaque in Patients with Diabetes Mellitus",
keywords = "Editorials, cardiovascular disease, coronary artery disease, diabetes mellitus, fluoride, inflammation, ischemic heart disease, patients",
author = "Zaha, {Vlad G.} and Joshi, {Parag H.} and McGuire, {Darren K.}",
note = "Funding Information: This work was supported in part by awards from the Cancer Prevention Institute of Texas and National Health Institute to V.G. Zaha. Funding Information: V.G. Zaha acts as noncompensated site principal investigator for a trial sponsored by Boehringer Ingelheim; P.H. Joshi receives significant grant support from American Heart Association, Novo Nordisk; acts as consultant for Regeneron (modest); and noncompensated site principal investigator for a trial sponsored by AstraZeneca, GlaxoSmithKline, Pfizer, and Regeneron/Sanofi. D.K. McGuire receives honoraria for Clinical trial leadership from AstraZeneca, Sanofi Aventis, Janssen, Boehringer Ingelheim, Merck & Co, Novo Nordisk, Lexicon, Eisai, Inc, GlaxoSmithKline, Esperion; acts as consultant for AstraZeneca, Sanofi Aventis, Eli Lilly and Company, Boehringer Ingelheim, Merck & Co, Pfizer, Novo Nordisk, Metavant, and Applied Therapeutics.",
year = "2019",
month = feb,
day = "1",
doi = "10.1161/ATVBAHA.118.312227",
language = "English (US)",
volume = "39",
pages = "124--125",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "2",
}